Marksans Pharma share news, announcements and annual reports
NSE: MARKSANSBSE: 524404Pharmaceuticals & BiotechnologySmall Cap
Marksans Pharma Limited · Formerly Tasc Pharmaceuticals · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1994 on BSE, Jan 2002 on NSE
Last close ₹306.20down ₹9.15 (2.90%)BSE ₹306.65
Share price at the NSE close on 30 Oct 2026. Previous close ₹315.35.
30 Oct: open ₹317.00, high ₹317.35, low ₹304.90
52-week range of traded prices to 30 Oct 2026
₹155.00Low, 30 Mar 2026₹350.95High, 24 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹13,876 Cr592nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.85
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.59
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.29%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 17.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 12,10,63344.3% delivered
Marksans Pharma board meetings
119 filed, newest first. Page 3 of 3.
Jun 2009
15 Jun · Board meeting
To consider and approve the Annual Audited Financial Results for the year ended March 31, 2009.
Jan 2009
20 Jan · Board meeting
To consider the following business: 1) To take on records Un-audited (Provisional) quarterly results for the quarter ended December 31, 2008; 2) Any other business with the permission of the Chair.
Oct 2008
20 Oct · Board meeting
To consider the following business : 1) To take on record Un-audited (Provisional) quarterly results for the quarter ended September 30, 2008. 2) Any other business with the permission of the Chair.
Sep 2008
23 Sep · Board meeting
At the meeting of the Board of Directors of the Company held on September 23, 2008, it was decided to make allotment of 8400241 equity shares of Re. 1/- to M/s. Bamacle LLc on preferential allotment basis.15 Sep · Board meeting
Board Meeting scheduled to be held on September 16, 2008, to make allotment of 8400241 Equity shares of Re. 1/- to M/s. Bamacle LLc on preferential allotment basis, has been postponed to be held on September 23, 2008 to transact the same agenda.8 Sep · Board meeting
To make allotment of 8400241 Equity shares of Re. 1/- to M/s. Bamacle LLc on preferential allotment basis, if approved by the shareholders at the Extra Ordinary General Meeting to be held on September 10, 2008.4 Sep · Board meeting
At the meeting of the Board of Directors of the Company held on September 02, 2008 the following decisions were taken: (1) Adoption of Audited Annual Accounts of the Company for the year ended March 31, 2008, along with Auditors report, Directors report, Corporate Governance Report and management Analysis and Discussion report. (2) Appointment of Statutory Auditors of the Company subject to the approval of the members of the Company. (3) Approval of ESOP scheme for the employees of the Company. (4) Approval of the notice of the Annual General Meeting and fixation of the day, date, time and place of the Annual General Meeting. (5) Fixation of Book Closure dates for the purpose of the Annual General Meeting.
Aug 2008
27 Aug · Board meeting
To consider and adopt: 1) Audited Annual Accounts of the Company for the year ended March 31, 2008, along with Auditors report, Directors report, Corporate Governance Report and management Analysis and Discussion report. 2). To consider appointment of Statutory Auditors of the Company. 3). To consider and approve ESOP scheme for the employees of the Company. 4). To approve the draft of notice of the Annual General Meeting. 5). Fix the day, date, time and place of the Annual General Meeting. 6). To fix book Closure dates for the purpose of the Annual General Meeting. 7). Any other business with the permission of the Chair.
Jul 2008
18 Jul · Board meeting
To consider the following business : 1) To take on record Un-audited (Provisional) quarterly results for the quarter ended June 30, 2008. 2) Any other business with the permission of the Chair.
Apr 2008
23 Apr · Board meeting
To consider the following business: 1) to take on records Un-audited (Provisional) quarterly results for the quarter ended March 31, 2008. 2) Any other business with the permission of the Chair.
Mar 2008
28 Mar · Board meeting
At the meeting of the Board of Directors of the Company held on 27th March,2008, it was decided to redeem 13,50,000 Redemption Cumulative Redeemable Preference Shares of Rs.100/- each issued by the Company in March, 2003 and due for redemption on 27.03.2008 by way of issue of Cumulative Redeemable Preference Shares for the same amount as due for redemption and on the same terms and conditions as earlier. The said shares will be due for redemption on 27th March, 201326 Mar · Board meeting
To consider and approve redemption of Cumulative Redeemable Preference Shares issued by the Company and due for redemption on March 27, 2008 by way of issue of Cumulative Redeemable Preference Shares for the same amount as due for redemption and on the same terms and conditions as earlier.
Feb 2008
27 Feb · Board meeting
To declare the results of the postal ballot and to decide the record date for the purpose of sub - division of the Equity shares of the Company.
Jan 2008
8 Jan · Board meeting
To consider the following business: 1) To take on records Un-audited (Provisional) quarterly results for the quarter ended December 31, 2007. 2) To consider Sub division of the Equity Shares capital of the Company. 3) Any other business with the permission of the Chair.
Oct 2007
17 Oct · Board meeting
To consider the following business: 1) To take on records Un-audited (Provisional) quarterly results for the quarter ended September 30, 2007. 2) Any other business with the permission of the Chair.
Aug 2007
28 Aug · Board meeting
To consider and adopt: 1) Audited Annual Accounts of the Company for the year ended March 31, 2007 along with Auditors report, Directors report, Corporate Governance Report and management Analysis and Discussion report. 2) To consider appointment of Statutory Auditors of the Company. 3) To approve the draft notice of the Annual General Meeting. 4) Fix the day, date, time and place of the Annual General Meeting. 5) To fix the book Closure dates for the purpose of the Annual General Meeting. 6) Any other business with the permission of the Chair.
Jul 2007
20 Jul · Board meeting
To consider the following business: (1) To take on records Un-audited (Provisional) quarterly results for the quarter ended June 30, 2007. (2) Any other business with the permission of the Chair.
Apr 2007
19 Apr · Board meeting
To consider the following business: 1) To take on records Un-audited (Provisional) quarterly results for the quarter ended March 31, 2007. 2) Any other business with the permission of the Chair.
Jan 2007
22 Jan · Board meeting
To consider the following business: 1) To take on records Un-audited (Provisional) quarterly results for the quarter ended December 31, 2006. 2) Any other business with the permission of the Chair.